Partnership – Page 3

Merck & Co. Enters Oral GLP-1 Market with $2 Billion Hansoh Pharma Deal

8 months ago talkbio0Tagged GLP-1 receptor, Hansoh Pharma, Merck & Co., Obesity, Oral cavity, Partnership, pharmaceutical collaboration

Merck & Co., Hansoh Pharma, GLP-1 receptor agonist, oral obesity treatment, pharmaceutical collaboration, biotech partnership

Relay Therapeutics Partners with Elevar Therapeutics in $500M Deal for Lirafugratinib in Rare Cancer Treatment

9 months ago talkbio0Tagged biotech, Cancer Therapeutic Procedure, Cholangiocarcinoma, Infrequent, Lirafugratinib, Partnership, Relay Therapeutics

Relay Therapeutics, Elevar Therapeutics, Lirafugratinib, FGFR2-Driven Cholangiocarcinoma, Rare Cancer Treatment, Biotech Partnership

Gilead Partners with Tubulis to Revitalize ADC Pipeline

9 months ago talkbio0Tagged Antibody-Drug, Antibody-Drug Conjugates, Biotechnology, Gilead Sciences, Immunostimulating conjugate (antigen), Malignant Neoplasms, Partnership, Tubulis

Gilead Sciences, Tubulis, Antibody-Drug Conjugates (ADCs), Cancer Treatment, Biotechnology Partnership

Gilead Partners with Tubulis for Solid Tumor ADC Development in Deal Worth Up to $465M

9 months ago talkbio0Tagged ADC, biotech, Gilead, Partnership, Solid Neoplasm, therapeutic autologous dendritic cells, Tubulis

Gilead, Tubulis, ADC, Solid Tumor, Biotech, Partnership

Eli Lilly Commits £279 Million to UK Life Sciences Sector in Groundbreaking Partnership

11 months ago talkbio0Tagged Biological Science Disciplines, Eli, Eli Lilly, Gateway Labs, Government, Investments, Obesity, Partnership, UK

Eli Lilly, UK life sciences, £279 million investment, Lilly Gateway Labs, obesity treatment, UK government partnership

Metsera and Amneal Collaborate on Next-Generation Obesity Medicines, with Leadership Transition at Metsera

11 months ago talkbio0Tagged Amneal, Leadership, Manufacture, Metsera, Obesity, Partnership, strategic collaboration, Transition Mutation

Metsera, Amneal, Obesity Drugs, Strategic Collaboration, Manufacturing Partnership, Leadership Transition

Bayer and NextRNA Therapeutics Collaborate on $547 Million Deal to Develop Innovative Cancer Therapies Targeting Long Non-Coding RNAs

12 months ago talkbio0Tagged Bayer, Drug Development, Long Intergenic Non-Protein Coding RNA, Neoplasms, NextRNA, Partnership

Bayer, NextRNA Therapeutics, lncRNA, small molecules, cancer, oncology, partnership, drug development

Pfizer and Flagship’s Quotient Therapeutics Collaborate to Identify Novel Targets for Cardiovascular and Renal Diseases

12 months ago talkbio0Tagged Cardiovascular Diseases, Drug Development, Flagship, Kidney Diseases, Partnership, Pfizer, Pioneering, somatic genomics

Pfizer, Flagship Pioneering, Quotient Therapeutics, cardiovascular diseases, renal diseases, somatic genomics, drug development, partnership

Walgreens and BARDA Collaborate on $100M Decentralized Clinical Trials Initiative

1 year ago talkbio0Tagged BARDA, Clinical Trials, decentralized, Health Services Research, Partnership, Walgreens

Walgreens, BARDA, Decentralized Clinical Trials, $100M Partnership, Healthcare Research

GSK Partners with Flagship Pioneering to Develop 10 Novel Medicines and Vaccines

1 year ago talkbio0Tagged bioplatform companies, Drug Discovery, Flagship, Immunology, Partnership, Pfizer, Pioneering, Respiration Disorders, RNA, Messenger, SmithKline Beecham, Vaccines

GSK, Flagship Pioneering, drug discovery, vaccines, respiratory disease, immunology, bioplatform companies, mRNA vaccines, Pfizer, biotech partnership